Analyst Ratings for Fresenius Medical Care (FMS) [Buys]
FMS Rating Summary
FMS Price Target Summary
- Highest: $74.00 (Piper Jaffray)
- Lowest: $36.00 (RBC Capital)
- Average: $55.00
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$55.00 (+55.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2013 | Barclays | Upgrade | Overweight (Equalweight) |
N/A (N/A) |
34.49 | 35.46 | 2.81% | Details |
| 1/14/2013 | Berenberg | Upgrade | Buy (Hold) |
N/A (N/A) |
32.26 | 35.46 | 9.92% | Details |
| 11/12/2012 | Goldman Sachs | Upgrade | Conviction Buy (Buy) |
N/A (N/A) |
66.66 | 35.46 | -46.8% | Details |
| 8/31/2012 | Societe Generale | New Coverage | Buy (N/A) |
N/A (N/A) |
71.25 | 35.46 | -50.23% | Details |
| 12/1/2011 | Morgan Stanley | Upgrade | Overweight (N/A) |
N/A (N/A) |
69.01 | 35.46 | -48.62% | Details |
| 8/26/2010 | RBS | New Coverage | Buy (N/A) |
N/A (N/A) |
57.76 | 35.46 | -38.61% | Details |
